News

download9

ZetaMet Receives Health Canada Authorization For Phase 2A Study In Treating Metastatic Bone Lesions

Press Release provided by Zetagen January 18th, 2022, (Syracuse New York) - Zetagen Therapeutics, a private, clinical-stage, biopharmaceutical company dedicated to driving breakthrough innovation in the treatment of metastatic bone cancers and osteologic interventions, today announced it has recei...
ZetaMet Receives Health Canada Authorization For Phase 2A Study In Treating Metastatic Bone Lesions
download8

EndoGlow Has Received Notification that the European Patent Office has Formally Announced its intention to grant a European Patent for our GreenEgg and Tissue Reveal Technology! Expect a lot more great news from EndoGlow in 2022!

EndoGlow has received notification that the European Patent Office has formally announced its intention to grant a European patent for our GreenEgg and Tissue Reveal Technology! Expect a lot more great news from EndoGlow in 2022! [Endoglow LinkedIn announcement, January 14, 2022]
JelikaLiteLogo

CNYBAC MDIC 2021 Team JelikaLite to Participate at 2nd Annual Princeton Women Founders Startup Showcase

Princeton Entrepreneurship Council is pleased to present the 2nd annual Women Founders Startup Showcase. This year’s event will feature six outstanding Princeton founders who represent faculty/postdoc, graduate alumna, and undergraduate alumnae across the Princeton entrepreneurial community.Marya...
CNYBAC MDIC 2021 Team JelikaLite to Participate at 2nd Annual Princeton Women Founders Startup Showcase
download7

CNYBAC Client Aurie Receives FDA Safer Technology Designation for its Reusable Intermittent Catheter System

Published By: Aurie Oct 11, 2021NEW YORK, October 11, 2021 — Aurie, a human-centered medical device company developing an automated reusable self-catheter system, announced today that the Aurie Reusable Intermittent Catheter System has received the Safer Technology designation from the U. S. Food ...
CNYBAC Client Aurie Receives FDA Safer Technology Designation for its Reusable Intermittent Catheter System
JelikaLiteLogo2

JelikaLite, a CNYBAC MDIC 2021 Team, Granted FDA Breakthrough Device Designation:

Provided by Business Wire- 1/6/21 NEW YORK--(BUSINESS WIRE)--JelikaLite Corp, a medical technology company, announced today that the U.S. Food and Drug Administration (FDA) has granted the Breakthrough Device Designation to its Cognilum System for the reduction of symptoms of moderate to severe auti...
JelikaLite, a CNYBAC MDIC 2021 Team, Granted FDA Breakthrough Device Designation:

CNYBAC Clients Achieve Major Milestones

Quadrant Biosciences (https://quadrantbiosciences.com/) Developing molecular diagnostic solutions for large-scale health issues.Clarifi COVID-19 saliva test kit developed in partnership with SUNY Upstate Medical University (wastewater surveillance testing, pooled saliva testing, individual saliva te...
CNYBAC Clients Achieve Major Milestones
CNY Biotech Accelerator Upstate Medical University

CNYBAC awarded Certified Business Incubator Grant

CNY Biotech Accelerator, Upstate Medical University has been awarded redesignation as a Certified Business Incubator through The Regional Economic Development Council to support their programs for an additional 5 years.  Programs include:  Medical Device Innovation Challenge (applications accepted...
CNYBAC awarded Certified Business Incubator Grant
download6

More Great News for CNYBAC Client Zetagen Therapeutics: Zetagen Announces the National Cancer Institute (NCI) has Awarded Zetagen with a Phase II $2 Million Grant for the Expanded Development of ZetaMet

ZETAGEN THERAPEUTICS AWARDED $2 MILLION USD GRANT FROM THE NATIONAL CANCER INSTITUTE (NCI) FOR PHASE 2 STUDY OF ZETAMET™ FOR TREATMENT OF METASTATIC BONE CANCERS(Zetagen Therapeutics Press Release:  December 13, 2021) Zetagen Therapeutics, Inc., a private, clinical-stage, biopharmaceutical comp...
More Great News for CNYBAC Client Zetagen Therapeutics: Zetagen Announces the National Cancer Institute (NCI) has Awarded Zetagen with a Phase II $2 Million Grant for the Expanded Development of ZetaMet

CNY Biotech Accelerator 2021 Medical Device Innovation Challenge Team, MindTrace, Accepted into AlphaLab Health 2021-2022 Cohort

Provided  By: PITTSBURGH (PRWEB) DECEMBER 03, 2021Healthcare and life sciences accelerator AlphaLab Health today announced the second cohort of start-up companies to participate in their program. The companies were competitively selected to participate in a six-month program that will help them ...
CNY Biotech Accelerator 2021 Medical Device Innovation Challenge Team, MindTrace, Accepted into AlphaLab Health 2021-2022 Cohort
download 2

Cayuga County Partners with Local Syracuse Company for Community COVID Testing Site

Cayuga County Partners with Local Syracuse Company for Community COVID Testing Site  Cayuga County has partnered with Syracuse-based Quadrant Biosciences to open a COVID testing site for symptomatic members of the community. The new site, located in the old Joann Fabrics in the Fingerlakes Mall at ...
Cayuga County Partners with Local Syracuse Company for Community COVID Testing Site

1 2 3 4 5 ... 7